- Home
- GPRE vs ABUS Comparison
GPRE vs ABUS Comparison
Compare GPRE & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRE
- ABUS
- Stock Information
- Founded
- GPRE 2004
- ABUS N/A
- Country
- GPRE United States
- ABUS United States
- Employees
- GPRE N/A
- ABUS N/A
- Industry
- GPRE Major Chemicals
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- GPRE Industrials
- ABUS Health Care
- Exchange
- GPRE Nasdaq
- ABUS Nasdaq
- Market Cap
- GPRE 684.0M
- ABUS 629.1M
- IPO Year
- GPRE N/A
- ABUS N/A
- Fundamental
- Price
- GPRE $9.90
- ABUS $3.21
- Analyst Decision
- GPRE Strong Buy
- ABUS Strong Buy
- Analyst Count
- GPRE 9
- ABUS 4
- Target Price
- GPRE $26.06
- ABUS $5.50
- AVG Volume (30 Days)
- GPRE 1.4M
- ABUS 876.5K
- Earning Date
- GPRE 02-05-2025
- ABUS 02-27-2025
- Dividend Yield
- GPRE N/A
- ABUS N/A
- EPS Growth
- GPRE N/A
- ABUS N/A
- EPS
- GPRE N/A
- ABUS N/A
- Revenue
- GPRE $2,587,166,000.00
- ABUS $6,742,000.00
- Revenue This Year
- GPRE N/A
- ABUS N/A
- Revenue Next Year
- GPRE $8.25
- ABUS N/A
- P/E Ratio
- GPRE N/A
- ABUS N/A
- Revenue Growth
- GPRE N/A
- ABUS N/A
- 52 Week Low
- GPRE $8.81
- ABUS $2.27
- 52 Week High
- GPRE $25.24
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- GPRE 49.28
- ABUS 43.07
- Support Level
- GPRE $9.03
- ABUS $3.16
- Resistance Level
- GPRE $10.45
- ABUS $3.38
- Average True Range (ATR)
- GPRE 0.53
- ABUS 0.14
- MACD
- GPRE 0.11
- ABUS 0.00
- Stochastic Oscillator
- GPRE 66.46
- ABUS 19.51
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in three segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities. The partnership segment provides fuel storage and transportation services.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.